The present stock price for Ginkgo Bioworks Holdings Inc (DNA) is $11.32. In the last trading session, the stock made a considerable jump, reaching $12.0 after an opening price of $11.32. The stock briefly fell to $6.0 before ending the session at $10.13.
Ginkgo Bioworks Holdings Inc experienced a rather steady stock market performance.
52-week price history of DNA Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Ginkgo Bioworks Holdings Inc’s current trading price is -32.82% away from its 52-week high, while its distance from the 52-week low is 126.40%. The stock’s price range during the 52-week period has remained between $5.00 and $16.85. In the Healthcare sector, the company’s shares saw a trading volume of around 2.6 million for the day, which was evidently higher than the average daily volume of 1.27 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Ginkgo Bioworks Holdings Inc (DNA) has experienced a quarterly rise of 44.20% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 662.58M and boasts a workforce of 834 employees.
A Closer Look at Analysts’ Ratings for Ginkgo Bioworks Holdings Inc
As of right now, 1 analyst is rating Ginkgo Bioworks Holdings Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 2 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.08, with a change in price of +1.03. Similarly, Ginkgo Bioworks Holdings Inc recorded 1,401,655 in trading volume during the last 100 days, posting a change of +10.01%.
Examining DNA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for DNA stands at 0.67. Similarly, the long-term debt-to-equity ratio is also 0.67.
DNA Stock Stochastic Average
As of today, Ginkgo Bioworks Holdings Inc’s raw stochastic average for the last 50 days stands at 69.91%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 60.49%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 42.76% and 33.83%, respectively.
DNA Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The index has shown a price loss of -14.84% this year. Over the last six months, there has been a weaker performance of 10.98%. The price of DNA fallen by 31.93% during the last 30 days period. For the last 5-days stocks have improved 13.88%.
